A cross-sectional study of the effects of type 2 diabetes and other cardiovascular risk factors on structure and function of nonstenotic arteries of the lower limb

Diabetes Care

Volumn 26, Issue 1, 2003, Pages 199-205

  O'Neal, David N ^a   Dragicevic, George ^a   Rowley, Kevin G ^a   Ansari, Mohamed Z ^a   Balazs, Nicholas ^b   Jenkins, Alicia ^a   Best, James D ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BLOOD CLOTTING FACTOR 7; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; LIPID; LOW DENSITY LIPOPROTEIN; RETINOL; TRIACYLGLYCEROL;

ADULT; ARTERY OCCLUSION; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INTIMA; LEG; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; POPLITEAL ARTERY; PULSE WAVE; RISK FACTOR; STRUCTURE ACTIVITY RELATION; SUPERFICIAL FEMORAL ARTERY; TRIACYLGLYCEROL BLOOD LEVEL; TUNICA MEDIA;

ADULT; AGED; BLOOD FLOW VELOCITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FEMORAL ARTERY; HUMANS; LEG; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POPLITEAL ARTERY; RISK FACTORS; TUNICA INTIMA;

EID: 0041669444     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.1.199     Document Type: Article

References (40)

1. Standl E, Steigler H, Janka H: Cerebral and peripheral vascular disease. In Prevention and Treatment of Diabetic Late Complications. Mogensen CE, Ed. New York, Standle E. de Gruyter, 1989, p. 169-198
2. Liang Y-L, Teede H, Kotsopoulos D, Shiel L, Cameron JD, Dart AM, McGrath BP: Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size. Clin Sci 95:669-679, 1998
3. Dauzat M, Deklunder G, Adam B, de Cesare A, Ayoub J, Masse-Biron J, Prefaut C, Peronneau P: Pulse wave velocity measurement by cross-correlation of Doppler velocity signals: application to elderly volunteers during training. Int J Sports Med 17:547-553, 1996
4. Bots ML, Breslau PJ, Briet E, de Bruyn AM, van Vliet HH, van den Ouweland FA, de Jong PT, Hofman A, Grobbee DE: Cardiovascular determinants of carotid artery disease: the Rotterdam Elderly Study. Hypertension 19:717-720, 1992
5. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, Rosamond W, Crow RS, Rautaharju PM, Heiss G: Arterial wall thickness is associated with prevalent cardiovascular disease in middle aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke 26:586-591, 1996
6. Allan PL, Mowbray PI, Lee AJ, Fowkes FG: Relationship between carotid intimamedia thickness and symptomatic and asymptomatic peripheral arterial disease: the Edinburgh Artery Study. Stroke 28:348-353, 1997
7. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, for the Cardiovascular Health Study Collaborative Research Group: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340:14-22, 1999
8. Wagenknecht LE, D'Agostino RB Jr, Haffner SM, Savage PJ, Rewers M: Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness. Diabetes Care 21:1812-1818, 1998
9. Pujia A, Gnasso A, Irace C, Colonna A, Mattioli PL: Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 17:1330-1336, 1994
10. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
11. Blackburn H: Electrocardiographic classification for population comparisons: the Minnesota code. J ECG 2:5-10, 1969
12. Lohman TG, Roche AF, Martorell R: Anthropometric Standardization Reference Manual. Champaign, Illinois, Human Kinetic Books, 1980
13. Zierler RE, Zierler BK: Duplex sonography of lower extremity arteries. In Introduction to vascular Ultrasonography. 3rd ed. Zwiebel WJ, Ed. Philadelphia, W.B. Saunders, 1992, p. 237-251
14. Bernstein EF, Fronek A: Current status of non-invasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Arn 62:473-487, 1982
15. Zierler RE, Strandness DE Jr: Nonimaging physiologic tests for assessment of extremity arterial disease. In Introduction to Vascular Ultrasonography. 3rd ed. Zwiebel WJ, Ed. Philadelphia, W.B. Saunders, 1992, p. 201-221
16. Fowkes FGR: The measurement of atherosclerotic peripheral arterial disease in epidemiological studies. Int J Epidemiol 17:248-254, 1988
17. O'Neal DN, Lewicki J, Ansari MZ, Matthews PG, Best JD: Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects. Atherosclerosis 136:1-8, 1998
18. O'Neal DN, Lee P, Murphy B, Best JD: Low density lipoprotein particle size in end-stage renal disease treated with haemodialysis or peritoneal dialysis. Am J Kidney Dis 27:84-91, 1996
19. Esterbauer H, Streigl G, Puhl H, Rothenader M: Continuous monitoring of in vitro oxidation of LDL. Free Rad Res Comm 6:67-75, 1989
20. O'Neal DN, O'Brien RC, Timmins KL, Grieve GD, Lau KP, Nicholson GC, Kotowicz MA, Best JD: Gemfibrozil treatment increases low density lipoprotein particle size in type 2 diabetes mellitus but does not alter in vitro oxidizability. Diabet Med 15:870-877, 1998
21. Su Q, Rowley KG, O'Dea K: Stability of individual carotenoids, retinol and tocopherol in human plasma during exposure to light and after extraction. J Chrom B-Biomed Applic 729:191-198, 1999
22. Washko PW, Welch RW, Dharjwal KR, Wang Y, Levine M: Ascorbic acid and dehydroascorbic acid analysis in biological samples. Anal Biochem 204:1-14, 1992
23. 1c. Diabetes 27:102-107, 1978
24. James WPT: The epidemiology of obesity. In The Origins and Consequences of Obesity. Chadwick D, Cardew G, Eds. Chichester, UK, Wiley, 1996, p. 1-16
25. Tenkanen L, Pietila K, Manninen V, Manttari M: The triglyceride issue revisited: findings from the Helsinki Heart Study. Arch Intern Med 154:2714-2720, 1994
26. Silver FH, Christianen DL, Buntin CM: Mechanical properties of the aorta: a review. Crit Rev Bio Engin 17:323-358, 1989
27. Albertini J-P, Valensi P, Lormeau B, Aurousseau MH, Ferriere F, Attali J-R, Gattegno L: Elevated concentration of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Diabetes Care 21:1008-1013, 1998
28. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators: Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size and physical activity. Stroke 25:66-73, 1994
29. Hanefeld M, Koehler C, Schaper F, Fuecker K, Henkel E, Temelkova-Kurtschiev T: Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis 144:229-235, 1999
30. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR: Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC Study. Circulation 91:1432-1443, 1995
31. Giltay EJ, Lambert J, Elbers JMH, Gooren LJG, Asscheman H, Stehouwer CDA: Arterial compliance and distensibility are modulated by body composition in both men and women but by insulin sensitivity in women. Diabetologia 42:214-221, 1999
32. O'Donnell TF Jr, Erdoes L, Mackey WC, McCullough J, Shepard A, Heggerick P, Isner J, Callow AD: Correlation of B-mode ultrasound imaging and arteriography with pathologic findings at carotid endarterectomy. Arch Surg 120:443-449, 1985
33. Smilde TJ, van den Berkmortel FWPJ, Boers GHJ, Wollersheim H, de Boo, T, van Langen H, Stalenhoef AFH: Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia. Arteroscler Thromb Vasc Biol 18:1958-1963, 1998
34. Parthasarthy S, Steinberg D, Witzum JL: Role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med 43:219-225, 1992
35. Panes J, Perry M, Granger DN: Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br J Pharmacol 126:537-550, 1999
36. Gryglewski RJ, Palmer RM, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature 320:454-456, 1986
37. Miyata T, Inagi R, Asahi K, Yamada Y, Horie K, Sakai H, Uchida K, Kurokawa K: Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids. FESS Lett 437:24-28, 1998
38. Kritchevsky SB, Shimakawa T, Tell GS, Dennis B, Carpenter M, Eckfeldt JH, Peacher-Ryan H, Heiss G: Dietary antioxidants and carotid artery wall thickness. The ARIC Study. Circulation 92:2142-2150, 1995
39. Azen SP, Qian D, Mack WJ, Sevanian A, Selzer RH, Liu C-R, Hodis HN: Effect of supplementary antioxidant vitamin intake on carotid arterial intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 94:2369-2372, 1996
40. Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, Alberti KGMM: Social inequality in coronary risk: central obesity and the metabolic syndrome: evidence from the Whitehall II study. Diabetologia 40:1341-1349, 1997